Spero Therapeutics, Inc.

SPRO · Nasdaq · SIC 2834: Pharmaceutical Preparations
167
SEC Filings

Business Summary

Part I Item 1A. Risk Factors and elsewhere in this Annual Report on Form 10-K. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we assume no obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future. This Annual Report on Form 10-K also contains estimates, projections and other information concerning our industry, our business, and the market...

Next Earnings

Q2 FY2026 — expected 2026-08-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSPROdiscussed_in_filing Cybersecurity
topic_mentionSPROdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001193125-26-126192EDGAR100K words
2025-03-272024-12-310000950170-25-046125EDGAR—
2024-03-132023-12-310000950170-24-030767EDGAR—
2023-03-302022-12-310000950170-23-010921EDGAR—
2022-03-312021-12-310000950170-22-005194EDGAR—
2021-03-112020-12-310001564590-21-012514EDGAR—
2020-03-162019-12-310001564590-20-010998EDGAR—
2019-03-142018-12-310001564590-19-007805EDGAR—
2018-04-022017-12-310001564590-18-007402EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001193125-25-280174EDGAR68K words
2025-08-122025-06-300000950170-25-107388EDGAR—
2025-05-132025-03-310000950170-25-070380EDGAR—
2024-11-142024-09-300000950170-24-127016EDGAR—
2024-08-052024-06-300000950170-24-090782EDGAR—
2024-05-152024-03-310000950170-24-060400EDGAR—
2023-11-132023-09-300000950170-23-062897EDGAR—
2023-08-102023-06-300000950170-23-041314EDGAR—
2023-05-112023-03-310000950170-23-021187EDGAR—
2022-11-142022-09-300000950170-22-024971EDGAR—
2022-08-102022-06-300000950170-22-016443EDGAR—
2022-05-162022-03-310000950170-22-010064EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-260001193125-26-126244EDGAR3K words
2026-01-300001193125-26-032004EDGAR—
2025-12-190001193125-25-325821EDGAR—
2025-11-130001193125-25-280518EDGAR—
2025-08-120001193125-25-178970EDGAR—
2025-06-180001193125-25-142807EDGAR—
2025-05-280001193125-25-128680EDGAR—
2025-05-130001193125-25-118882EDGAR—
2025-04-280001193125-25-100433EDGAR—
2025-03-270001193125-25-065633EDGAR—

167 total filings indexed. 136 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001701108
TickerSPRO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e002f85796571adcffb7a192f55a82a0b2a2b0b17e6ee8bbb5fb7be327c35eab
parent: e1bf30af5fc1c947a98d685751b91aa8cd109ac8f1e8c65c322d4b52d373e0c4
content hash: a66f5d62f8abad3d6934a8af43db626569a61493491600714aced1f19c6e6a58
signed: 2026-04-13T04:47:34.775Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf